Use of GLP-1 weight-loss drugs is growing rapidly and changing what people eat - but while the food industry is planning for smaller portions and high-protein ranges, the potential environmental impacts risk being overlooked, writes Isabel Wallis from SB+CO, part of SLR
The scale of the use of GLP-1 weight loss drugs is worth pausing on. In the US, the share of adults taking a GLP-1 for weight loss went from three per cent to 11 per cent in two years. Almost all of that...
To continue reading this article...
Join BusinessGreen
In just a few clicks you can start your free BusinessGreen Lite membership for 12 months, providing you access to:
- Three complimentary articles per month covering the latest real-time news, analysis, and opinion from Europe’s leading source of information on the Green economy and business
- Receive important and breaking news stories via our daily news alert
- Our weekly newsletter with the best of the week’s green business news and analysis
